Ketamine for Treatment-Resistant Depression Ketamine for Treatment-Resistant Depression

Ketamine for Treatment-Resistant Depression

Neurobiology and Applications

    • 89,99 €
    • 89,99 €

Publisher Description

Ketamine for Treatment-Resistant Depression: Neurobiology and Applications provides a simple, evidence-based overview for neuropsychiatrists and translational researchers on this medication, its mechanisms of actions, eligibility of patients for treatment, and the preparation and implementation of ketamine clinics. Provides efficacy research on ketamine as a treatment for depression Identifies best practices for clinical use, both long-term and acute Discusses the molecular mechanisms and neurobiology of action

GENRE
Professional & Technical
RELEASED
2020
16 September
LANGUAGE
EN
English
LENGTH
168
Pages
PUBLISHER
Elsevier Science
SIZE
11.1
MB